Related references
Note: Only part of the references are listed.Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency
P. Brand et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Preparation of Active Proteins, Vaccines and Pharmaceuticals as Fine Powders using Supercritical or Near-Critical Fluids
Stephen P. Cape et al.
PHARMACEUTICAL RESEARCH (2008)
α1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
M. Griese et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Exacerbations in α1-antitrypsin deficiency
M Needham et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease
T Meyer et al.
EXPERIMENTAL LUNG RESEARCH (2003)
American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Peripheral deposition of α-protease inhibitor using commercial inhalation devices
P Brand et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Share Paper
